Target intelligence / Profile preview

Peptidoglycan (bacterial cell wall)

Molecular classification
Other (structural polysaccharide polymer), Enzyme (for cell wall biosynthetic proteins: Mur enzymes, penicillin-binding proteins)
01

Overview

The bacterial cell wall is a rigid, protective structure primarily composed of **peptidoglycan**, a mesh-like polymer of alternating N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM) units cross-linked by short peptide bridges[2][3][4][5]. This structure determines bacterial shape, prevents osmotic lysis, and is essential for viability[1][7][11]. Gram-positive bacteria have thick peptidoglycan layers with teichoic acids, while gram-negative bacteria have thin peptidoglycan surrounded by an outer membrane containing lipopolysaccharide[1][6][12][14]. Cell wall synthesis and remodeling involve numerous enzymes (Mur family, penicillin-binding proteins), many of which are validated antibiotic targets due to their essential roles in growth and division[9][4][11]. Therapeutic targeting of the cell wall or its biosynthetic proteins remains a cornerstone of antibacterial therapy, but clinical efficacy is challenged by resistance and drug hypersensitivity. Note: For structured information, "Peptidoglycan (bacterial cell wall)" is correct only if referring to the wall's polymeric structure. For a protein target, specify the protein (e.g., Penicillin-binding protein 2). "Bacterial cell wall/protein" as written is overly broad and should be clarified for data interoperability.

Other names
Bacterial cell wallmurein (for peptidoglycan)wall-associated proteins (not a formal alias, see note)
02

Mechanism of action

Inhibition of cell wall (peptidoglycan) biosynthesis (by blocking transpeptidase or other biosynthetic enzymes) Disruption of cell wall structure, leading to osmotic lysis and cell death[4][7][9]

03

Biological functions

Structural integrityProtection against osmotic lysisMaintenance of cell shapeCell divisionRegulation of cell growthImmune evasion/antigenic signaling[1][5][7]
04

Disease associations

InfectionAntibiotic resistance
05

Safety considerations

Hypersensitivity reactions to antibiotics (e.g., beta-lactam allergy)Emergence of resistance (e.g., MRSA, beta-lactamase-producing strains)Off-target effects impacting host microbiota
06

Interacting drugs

Beta-lactam antibiotics (e.g., penicillin, cephalosporin)

3 more in the full profile.

Beyond the preview

Go deeper on Peptidoglycan (bacterial cell wall).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peptidoglycan (bacterial cell wall).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call